Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Viatris Aktie: Kommt die Trendwende?
Viatris Aktie: Kommt die Trendwende?

Nach einer langen Talfahrt zeigt die Viatris-Aktie endlich wieder Lebenszeichen. Der Grund: Der Pharmakonzern…

Der Beitrag Viatris Aktie: Kommt die Trendwende? erschien zuerst auf kapitalmarktexpert

Viatris Misses Estimates, Cash Flow Up
Viatris Misses Estimates, Cash Flow Up

Viatris (NASDAQ:VTRS), a global healthcare company known for its broad portfolio of pharmaceutical products, released its fourth-quarter 2024 results on Feb. 27. Despite achieving substantial debt

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris


Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Viatris, Inc. (“Viatris” or the “Company”) (NASDAQ: VTRS) and reminds investors of the June